MAXVALUE CREDITS AND INVESTMENTS LIMITED

Course Description
Market Cap: | Book Value: | ||
---|---|---|---|
Lot Size: | 52 Week High: | ||
52 Week Low: | EPS: | ||
Demat Account: | PB: | ||
Face Value: | Debt To Equity: | ||
No Of Shares: | Web Site Url: |
Max India Limited is a multi-business corporate, driven by the spirit of enterprise and focused on people and service-oriented businesses. The Company's vision is to be one of India's most admired corporates for Service Excellence. It is a manufacturer of specialty plastic film products for packaging industry. The Company has invested in various subsidiaries in diversified businesses, such as healthcare, life insurance, health insurance, clinical research, etc. The Company is in the business of clinical research services to global pharmaceuticals, device and biotechnology companies through its 100% wholly owned subsidiary Max Neeman Medical International Limited (MNMI). The Company has two segments: Specialty Plastic products and Business Investments. Financial Summary (Amount in Rupees)
Description | 2020-21 | 2019-20 |
Total Income | 1,54,11,22,731 | 1,85,21,57,403 |
Total Expenditure | 1,54,55,29,239 | 1,84,65,70,915 |
Profit before prior period items and tax | (44,06,508) | 55,86,488 |
Prior period items | 0 | 0 |
Profit before tax | 17,54,054 | 55,86,488 |
Less: Deferred Tax | (66,95,285) | (83,57,698) |
Profit for the Year | 2,42,09,339 | 1,39,44,186 |
CONSOLIDATED
INCOME STATEMENTEquities & Liabilities | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
---|---|---|---|---|---|---|
Share Capital |
53 | 53 | 53 | 53 | 53 | |
Reserves & Surplus |
2,092 | 2,005 | 1,765 | 2,281 | 1,911 |
|
Current Liabilities |
2,311 | 2,302 | 2,098 | 5,195 | 1,400 |
|
Other Liabilities |
70,068 | 62,849 | 51,923 | 39,208 | 34,780 |
|
Total Liabilities |
74,526 | 67,210 | 55,841 | 46,739 | 38,146 |
|
Assets | ||||||
---|---|---|---|---|---|---|
Fixed Assets |
115 | 30 | 31 | 168 | 176 |
|
Current Assets |
71,339 | 65,414 | 54,652 | 6,368 | 3,926 |
|
Other Assets |
3,071 | 1,766 | 1,157 | 40,202 | 34,043 |
|
Total Assets |
74,526 | 67,210 | 55,841 | 46,739 | 38,146 |
|
Other Info | ||||||
---|---|---|---|---|---|---|
Contingent Liabilities |
123 | 164 | 332 | 474 | 573 |
|
Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|
Operating Activities |
9,467 | 8,826 | 7,533 | 6,525 | 3,802 |
|
Investing Activities |
-9,008 | -8,789 | -6,951 | -6,289 | -3,503 | |
Financing Activities |
-380 | -173 | -116 | -215 | -186 | |
Others |
0 | 0 | 0 | 0 | 0 |
|
Net Cash Flow |
78 | -136 | 465 | 20 | 112 |
|
Growth Ratios | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
---|---|---|---|---|---|---|
3 Yr CAGR Sales (%) |
9.44 | 29.11 | 5.01 | 14.45 | 5.23 |
|
3 Yr CAGR Net Profit (%) |
-32.18 | 2.92 | 10.04 | 68.29 | -31.97 |
|